Filing Flows › Regenxbio (RGNX) › How it makes money
How Regenxbio (RGNX) makes money
Regenxbio (RGNX) made $9.2M of revenue in the third quarter 2026 (Q3 2026), +50% from a year earlier. License and Service brought in $5.2M (57%); Service brought in $3.9M (43%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| License and Service | $5.2M | 57.2% | — | — |
| ↳ Itvisma Royalties | $2.8M | 30.7% | — | — |
| ↳ Zolgensma Royalties | $2.4M | 26.5% | — | -90% |
| Service | $3.9M | 42.8% | — | -36% |
| ↳ Nippon Shinyaku Services | $3.3M | 36.1% | — | -44% |
| ↳ Other Service Revenue | $609K | 6.6% | — | +211% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $9.2M | 100.0% |
| Operating cash flow | $38.6M | 421.4% |
| Free cash flow | $38.4M | 419.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $9.2M | -69% |
| Q2 2026 | $108M | +406% |
| Q1 2026 | $6.4M | -93% |
| Q4 2025 | $30.3M | +43% |
| Q3 2025 | $29.7M | +23% |
| Q2 2025 | $21.4M | -4% |
| Q1 2025 | $89.0M | +470% |
From Regenxbio's 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Regenxbio make money?
Regenxbio (RGNX) made $9.2M of revenue in the third quarter 2026 (Q3 2026), +50% from a year earlier. License and Service brought in $5.2M (57%); Service brought in $3.9M (43%).
What is Regenxbio's biggest business?
License and Service: $5.2M in the third quarter 2026, 57% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.